MARKET

AMGN

AMGN

Amgen Inc
NASDAQ
468.11
+2.88
+0.62%
After Hours: 468.21 +0.1 +0.02% 19:59 11/11 EST
OPEN
460.98
PREV CLOSE
465.23
HIGH
468.46
LOW
459.14
VOLUME
2.01M
TURNOVER
--
52 WEEK HIGH
483.99
52 WEEK LOW
306.12
MARKET CAP
253.21B
P/E (TTM)
27.14
1D
5D
1M
3M
1Y
5Y
1D
Regeneron Pharmaceuticals Inc. Stock Climbs 4.7%, Outperforms Peers
Dow Jones · 9h ago
Democratic senators probe gifts to RFK Jr. from large donor to his presidential campaign
Seeking Alpha · 10h ago
What Does Amgen (AMGN) FDA Warning Mean For Investors?
Simply Wall St · 14h ago
Amgen Experimental Drug Shows Symptom Reductions in Chronic Autoimmune Disease That Impacts Tears
Benzinga · 15h ago
Want $7,000 in Passive Income? Buy These 3 Dividend Stocks Today
24/7 Wall St. · 17h ago
Amgen slips after late-stage trial data for Sjögren's disease therapy
Seeking Alpha · 17h ago
Amgen's Dazodalibep Shows Phase 3 Success In Sjögren's Disease With No Approved Treatments Available
NASDAQ · 17h ago
Amgen reports results from Phase 3 OASIZ-301 study of dazodalibep
TipRanks · 18h ago
More
About AMGN
Amgen Inc. is a biotechnology company. It discovers, develops, manufactures and delivers medicines for the toughest diseases. It focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve people’s lives. It operates in the human therapeutics segment. Its marketed products portfolio includes EPOGEN (epoetin alfa); Aranesp (darbepoetin alfa); Parsabiv (etelcalcetide); Neulasta (pegfilgrastim); KANJINTI (trastuzumab-anns); Otezla; BLINCYTO (blinatumomab); ACTIMMUNE (interferon gamma-1b); Neulasta (pegfilgrastim); Sensipar/Mimpara (cinacalcet); Prolia (denosumab); ENBREL; QUINSAIR (levofloxacin); Repatha (evolocumab) and others. It markets ENBREL, a tumor necrosis factor blocker, in the United States and Canada. It markets Otezla, a small molecule that inhibits phosphodiesterase 4, in many countries around the world. It markets Repatha, a proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor, in many countries around the world.

Webull offers Amgen Inc stock information, including NASDAQ: AMGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AMGN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AMGN stock methods without spending real money on the virtual paper trading platform.